Treatment choices of hypertensive patients in Turkey

Behavioral Medicine

Volumn 33, Issue 1, 2007, Pages 5-10

  Toprak, Dilek ^a   Demir, Serap ^a  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

Author keywords

Hypertension; Patient behavior; Patient education; Patient knowledge

Indexed keywords

ANTIHYPERTENSIVE AGENT; YOGHURT;

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; BEHAVIOR MODIFICATION; BODY MASS; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; FOOD INTAKE; GARLIC; HEALTH BEHAVIOR; HEALTH STATUS; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; PRIMARY MEDICAL CARE; QUESTIONNAIRE; TRADITIONAL MEDICINE; TREATMENT INDICATION; TURKEY (REPUBLIC);

ADULT; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; BODY MASS INDEX; CHOICE BEHAVIOR; COMPLEMENTARY THERAPIES; DRUG THERAPY; FEMALE; HEALTH PROMOTION; HEALTH SERVICES; HUMANS; HYPERTENSION; LIFE STYLE; MALE; MIDDLE AGED; PHYTOTHERAPY; SOCIAL ENVIRONMENT; TURKEY;

EID: 34249079679     PISSN: 08964289     EISSN: None     Source Type: Journal    
DOI: 10.3200/BMED.33.1.5-10     Document Type: Article

References (28)

1. Jo I, Ahn Y, Lee J, Shin KR, Lee HK, Shin C. Prevalence, awareness, treatment, control, and risk factors of hypertension in Korea: the Ansan study. J Hypertens. 2001;19:1523-1532.
2. Gu D, Reynolds K, Wu X, et al. The International Collaborative Study of Cardiovascular Disease in ASIA: prevalence, awareness, treatment, and control of hypertension in China. Hypertension. 2002;40:920-927.
3. Ibrahim M, Rizk H, Appel L, et al. Hypertension prevalence, awareness, treatment, and control in Egypt: results from the Egyptian National Hypertension Project (NHP). Hypertension. 1995;26:886-890.
4. Kim JS, Kim SJ, Jones DW, Hong YP. Hypertension in Korea: a national survey. Am J Prev Med. 1994;10:200-204.
5. Roccella EJ, Burt V, Horan MJ, Cutler J. Changes in hypertension awareness, treatment, and control rates. Ann Epidemiol. 1993;3:547-549.
6. Soydan I. Results related with hypertension in the TEKHARF study and their interpretation. In: Onat A, ed. TEKHARF Coronary Risk Map and Coronary Heart Disease in Turk Adults [in Turkish]. Istanbul, Turkey: ARGOS; 2001:50-60.
7. He J, Whelton PK. Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J. 1999;138:211-219.
8. Dzerve V, Britcina N, Pakhomova J, Markovitcha I, Rinkuzs K, Mitjusheva G. Prevalence and control of hypertension in Latvia. J Hum Hypertens. 2004;18:587-590.
9. Poggi L, Chamontin B, Lang T, et al. Prevalence, treatment, and control of hypertension in family practice patients in France during 1994. Arch Mal Coeur Vaiss. 1996;89:1075-1080.
10. Yosefy C, Linov L, Viskoper JR, et al. Prior antihypertensive treatment and admission blood pressure correlated with clinical outcome and early morning presentation in hypertensive ischaemic stroke patients. J Hum Hypertens. 1999;13:765-769.
11. Milne FJ, Pinkney-Atkinson VJ. Southern African Hypertension Society: Hypertension Guideline Working Groups 2000 and 2003. Hypertension guideline 2003 update. S Afr Med J. 2004;94:209-216, 218, 220-225.
12. Bilir N, Guciz B, Yildiz N. Attitudes and Behaviors About Smoking [in Turkish]. Ankara, Turkey: Hacettepe Halk Sagligi Vakfi Yayini, No. 7; 1997.
13. World Health Organization Guidelines subcommittee. International Society of Hypertension guidelines for the management of hypertension, 1999. J Hypertens. 1999;17:151-183.
14. Taylor C, Ward A. Patients' views of high blood pressure, its treatment and risks. Aust Fam Physician. 2003;32:278-282.
15. Douglas JG, Ferdinand KC, Bakris GL, Sowers JR. Barriers to blood pressure control in African Americans: overcoming obstacles is challenging, but target goals can be attained. Postgrad Med. 2002;112:51-52, 55, 59-62.
16. Hirsch AT, Gloviczki P, Drooz A, Lovell M, Creager MA. Mandate for creation of a national peripheral arterial disease public awareness program: an opportunity to improve cardiovascular health. Int Angiol. 2004;23:5-13.
17. National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program Working Group report on primary prevention of hypertension. Arch Intern Med. 1993;153:186-208.
18. Glick M. The new blood pressure guidelines: a digest. J Am Dent Assoc. 2004;135:585-586.
19. Lin T, Chen CH, Chou P. Impact of the high-risk and mass strategies on hypertension control and stroke mortality in primary health care. J Hum Hypertens. 2004;18:97-105.
20. Anselmi M, Caicedo F, Caicedo O, et al. Community participation as a strategy of hypertension control in a health district of Ecuador. Assist Inferm Ric. 2004;23:5-13.
21. Vergara C, Martin AM, Wang F, Horowitz S. Awareness about factors that affect the management of hypertension in Puerto Rican patients. Conn Med. 2004;68:269-276.
22. Silagy CA, Neil HA. A meta-analysis of the effect of garlic on blood pressure. J Hypertens. 1994;12:463-468.
23. Mansoor GA. Herbs and alternative therapies. Am J Hypertens. 2001;14:971-975.
24. Chagan L, Ioselovich A, Asherova L, Cheng JW. Use of alternative pharmacotherapy in management of cardiovascular diseases. Am J Manag Care. 2002;8:270-285.
25. Gavagan T. Cardiovascular disease. Prim Care. 2002;29:323-338.
26. Ramsay LE. Compliance with weight reduction in hypertensive patients. J Hypertens Suppl. 1985;3:81-85.
27. Singh RB, Rastogi SS, Singh DS, Mehta PJ. Effects of obesity and weight reduction in hypertension. Acta Cardiol. 1990;45:45-56.
28. Mertens IL, Van Gaal LF. Overweight, obesity, and blood pressure: the effects of modest weight reduction. Obes Res. 2000;8:270-278.